(S1 (S (S (NP (NN Current)) (VP (VBZ prospects) (PP (IN for) (S (VP (VBG controlling) (NP (NP (NN cancer) (NN growth)) (PP (IN with) (NP (NP (JJ non-cytotoxic) (NNS agents)) (: --) (NP (NNS nutrients)) (, ,) (NP (NNS phytochemicals)) (, ,) (NP (JJ herbal) (NNS extracts)) (, ,) (CC and) (NP (JJ available) (NNS drugs)))))))))) (. .)))
(S1 (S (PP (IN In) (NP (NP (NN animal)) (CC or) (NP (NN cell) (NN culture) (NNS studies)))) (, ,) (NP (NP (DT the) (NP (NN growth)) (CC and) (NP (NN spread))) (PP (IN of) (NP (NN cancer)))) (VP (MD can) (VP (VB be) (VP (VBN slowed) (PP (IN by) (NP (NP (NP (JJ many) (NNS nutrients)) (, ,) (NP (JJ food) (NNS factors)) (, ,) (NP (JJ herbal) (NNS extracts)) (, ,) (CC and) (NP (ADJP (ADJP (JJ well-tolerated)) (, ,) (ADJP (JJ available))) (NNS drugs))) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADVP (RB still)) (ADVP (RB rarely)) (VP (VBN used) (PP (IN in) (NP (NP (DT the) (JJ clinical) (NN management)) (PP (IN of) (NP (NN cancer))))) (, ,) (PP (IN in) (NP (NN part))) (SBAR (IN because) (S (NP (PRP they)) (VP (VBP seem) (ADJP (JJ unlikely) (S (VP (TO to) (VP (VB constitute) (NP (NP (JJ definitive) (NNS therapies)) (PP (IN in) (NP (PRP themselves)))))))))))))))))))) (. .)))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (PRP it)) (VP (VBZ is) (ADJP (JJ reasonable)) (S (VP (TO to) (VP (VB expect) (SBAR (IN that) (S (NP (NP (ADJP (RB mechanistically) (JJ complementary)) (NNS combinations)) (PP (IN of) (NP (DT these) (NNS measures)))) (VP (VP (MD could) (VP (VB have) (NP (DT a) (JJ worthwhile) (NN impact)) (PP (IN on) (NP (NN survival) (NNS times))))) (CC and) (, ,) (SBAR (WHADVP (WRB when)) (S (VP (VBN used) (PP (IN as) (NP (NNS adjuvants)))))) (, ,) (VP (MD could) (VP (VB improve) (NP (NP (DT the) (NN cure) (NNS rates)) (ADJP (JJ achievable) (PP (IN with) (NP (JJ standard) (NNS therapies))))))))))))))) (. .)))
(S1 (S (S (NP (DT The) (JJ therapeutic) (NNS options)) (ADJP (JJ available) (PP (IN in) (NP (DT this) (NN regard)))) (S (VP (VBP include) (NP (NP (NNS measures)) (SBAR (SBAR (IN that) (S (: :) (S (VP (VB down-regulate) (NP (NN serum) (JJ free) (NN IGF-I)))) (: ;) (S (VP (VB suppress) (NP (NP (NP (NP (NP (DT the) (NN synthesis)) (PP (IN of) (NP (JJ mevalonic) (NN acid)))) (CC and/or) (NP (JJ certain) (NNS derivatives))) (ADVP (RB thereof))) (: ;) (S (VP (VB modulate) (NP (NN arachidonate) (NN metabolism)) (PP (IN by) (S (VP (VBG inhibiting) (NP (NP (NN 5-lipoxygenase)) (, ,) (NP (NN 12-lipoxygenase)) (, ,) (CC or) (NP (NN COX-2)))))))) (: ;) (S (VP (VB antagonize) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NN AP-1) (NN transcription) (NNS factors))))))))) (: ;) (S (VP (VB promote) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NN PPAR-gamma) (NN transcription) (NNS factors)))))) (: ;))) (CC and) (SBAR (IN that) (S (VP (VBP suppress) (NP (NN angiogenesis)) (PP (IN by) (NP (JJ additional) (NNS mechanisms))))))))))) (. .)))
(S1 (S (S (NP (NP (JJ Many)) (PP (IN of) (NP (DT these) (NNS measures)))) (VP (VBP appear) (ADJP (JJ suitable) (PP (IN for) (NP (NP (NN use)) (PP (IN in) (NP (NN cancer) (NN prevention)))))))) (. .)))
